HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.
| dc.contributor.author | Verkoczy, Laurent | |
| dc.contributor.author | Kelsoe, Garnett | |
| dc.contributor.author | Haynes, Barton F | |
| dc.contributor.editor | Racaniello, Vincent | |
| dc.coverage.spatial | United States | |
| dc.date.accessioned | 2015-11-18T16:33:11Z | |
| dc.date.issued | 2014-05 | |
| dc.identifier | ||
| dc.identifier | PPATHOGENS-D-13-02351 | |
| dc.identifier.eissn | 1553-7374 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Public Library of Science (PLoS) | |
| dc.relation.ispartof | PLoS Pathog | |
| dc.relation.isversionof | 10.1371/journal.ppat.1004073 | |
| dc.subject | AIDS Vaccines | |
| dc.subject | Antibodies, Neutralizing | |
| dc.subject | Autoantibodies | |
| dc.subject | Drug Discovery | |
| dc.subject | HIV Antibodies | |
| dc.subject | HIV Envelope Protein gp41 | |
| dc.subject | HIV Infections | |
| dc.subject | HIV-1 | |
| dc.subject | Humans | |
| dc.subject | Immune Tolerance | |
| dc.subject | Mutation | |
| dc.title | HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Verkoczy, Laurent|0000-0001-7497-6645 | |
| duke.contributor.orcid | Kelsoe, Garnett|0000-0002-8770-040X | |
| pubs.author-url | ||
| pubs.begin-page | e1004073 | |
| pubs.issue | 5 | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Duke Cancer Institute | |
| pubs.organisational-group | Duke Human Vaccine Institute | |
| pubs.organisational-group | Global Health Institute | |
| pubs.organisational-group | Immunology | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Institutes and Provost's Academic Units | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Medicine, Duke Human Vaccine Institute | |
| pubs.organisational-group | Pathology | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | University Institutes and Centers | |
| pubs.publication-status | Published online | |
| pubs.volume | 10 |
Files
Original bundle
- Name:
- HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.pdf
- Size:
- 321.87 KB
- Format:
- Adobe Portable Document Format